A Form 144 notice of proposed sale was filed on November 10, 2026, disclosing that the Anevski 2026 South Dakota NGCG Trust intends to sell 50,139 shares of Progyny, Inc. common stock on NASDAQ.

Key Highlights

  • Proposed sale: The Anevski 2026 South Dakota NGCG Trust plans to sell 50,139 shares of Progyny, Inc. common stock, with an aggregate market value of $1,802,497.05.
  • Approximate sale date: The filing lists November 10, 2026 as the approximate date of sale, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.
  • Source of shares: According to the filing, the securities were acquired through restricted stock units, performance stock units, and an employee stock purchase plan during the period January 1, 2022 through March 3, 2026.
  • Shares outstanding: The filing states 73,647,334 shares of Progyny common stock were outstanding at the time of the notice.
  • 10b5-1 plan: The filing indicates the sale is being made pursuant to a Rule 10b5-1 plan adopted on July 2, 2026.
  • Recent prior sales: During the past three months, 10b5-1 sales were reported for Peter Anevski and the trust, totaling 173,246 shares sold on November 5 and November 9, 2026, with gross proceeds of $6,182,253.89 combined.

Anevski Trust Files Rule 144 Notice for Progyny Share Sale

The Form 144 notice, filed November 10, 2026, identifies the Anevski 2026 South Dakota NGCG Trust as the account for whose benefit the proposed sale is to occur. The relationship to Progyny, Inc. (NASDAQ:PGNY) is listed as both Director and Officer in the filing. The broker named to execute the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

According to the filing, the 50,139 shares proposed for sale carry an aggregate market value of $1,802,497.05. The shares were acquired through restricted stock units, performance stock units, and an employee stock purchase plan, with an acquisition date listed as January 1, 2022 and payment described as "N/A & Cash." The remarks section of the filing states that "the securities to be sold were acquired upon the vesting of restricted stock units, performance stock units and employee purchase plan during the period of 1/1/2022 through 3/3/2026."

The filing also discloses sales made in the prior three months. Under the same 10b5-1 plan, Peter Anevski sold 126,204 shares on November 9, 2026 for gross proceeds of $4,508,726.24, and 3,400 shares on November 5, 2026 for $119,773.84. The Anevski 2026 South Dakota NGCG Trust sold 35,104 shares on November 9, 2026 for $1,254,114.97, and 8,539 shares on November 5, 2026 for $299,638.84. The 10b5-1 plan was adopted on July 2, 2026, according to the filing.

What Was Disclosed

Progyny, Inc. reported a Form 144 notice from the Anevski 2026 South Dakota NGCG Trust proposing to sell 50,139 shares of common stock valued at $1,802,497.05, pursuant to a Rule 10b5-1 plan adopted July 2, 2026, with the sale to be executed through Morgan Stanley Smith Barney LLC.